Condition: Acute Pancreatitis · Sponsor: University of Liverpool
This study evaluates the effectiveness and safety of infliximab in the treatment of acute pancreatitis in adults. A third of participants will receive one single dose of infliximab via infusion, another third will receive a higher dose of infliximab via infusion and the final third of participants will receive a placebo infusion.
This description comes directly from the study's public registry record.
Matt Smyth, BSc · (0) 151 794 9774 · rapid.one@liverpool.ac.uk
Catherine E Spowart, BSc · (0) 151 794 9776 · catherine.spowart@liverpool.ac.uk
Always discuss trial participation with your own doctor first.
| Aberdeen Royal Infirmary | Aberdeen, Aberdeenshire, United Kingdom | Recruiting |
| University Hospital of Wales | Cardiff, Cardiff, United Kingdom | Recruiting |
| Royal Cornwall Hospital | Truro, Cornwall, United Kingdom | Withdrawn |
| Royal Devon and Exeter Hospital | Exeter, Devon, United Kingdom | Recruiting |
| University College London Hospital | London, Greater London, United Kingdom | Recruiting |
| St Mary's Hospital | London, Greater London, United Kingdom | Terminated |
| Charing Cross Hospital | London, Greater London, United Kingdom | Terminated |
| Royal Liverpool University Hospital | Liverpool, Merseyside, United Kingdom | Recruiting |
| Aintree University Hospital | Liverpool, Merseyside, United Kingdom | Recruiting |
| Whiston Hospital | Whiston, Merseyside, United Kingdom | Terminated |
| Queen's Medical Centre | Nottingham, Nottinghamshire, United Kingdom | Terminated |
| John Radcliffe Hospital | Oxford, Oxfordshire, United Kingdom | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03684278